Depacon and Drug ineffective - a phase IV clinical study of FDA data

Summary:

Drug ineffective is reported as a side effect among people who take Depacon (valproate sodium), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Depakote, and have Migraine.

The phase IV clinical study analyzes which people have Drug ineffective when taking Depacon. It is created by eHealthMe based on reports of 252 people who have side effects when taking Depacon from the FDA, and is updated regularly.

What is Depacon?

Depacon has active ingredients of valproate sodium. eHealthMe is studying from 268 Depacon users. Check the latest studies of Depacon.

What is Drug ineffective?

Drug ineffective is found to be associated with 4,081 drugs and 5,194 conditions by eHealthMe. Check the latest studies of Drug ineffective.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

252 people reported to have side effects when taking Depacon.
Among them, 13 people (5.16%) have Drug ineffective.

Among these 13 people:

How long have people been on Depacon when they have Drug ineffective? *

What is the gender of people who have Drug ineffective when taking Depacon? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Drug ineffective when taking Depacon? *

What are other drugs people take besides Depacon? *

What are other side effects people have besides Drug ineffective? *

Weakness: 3 people, 23.08%
Dyspnea (difficult or laboured breathing): 3 people, 23.08%
Weight Increased: 2 people, 15.38%
Pharyngeal Oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal): 2 people, 15.38%
Back Pain: 2 people, 15.38%
Blood Amylase Increased: 2 people, 15.38%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 2 people, 15.38%
Chest Pain: 2 people, 15.38%
Electroencephalogram Abnormal: 2 people, 15.38%
Gait Disturbance: 2 people, 15.38%

What are the existing conditions these people have? *

Migraine (headache): 6 people, 46.15%
Depression: 2 people, 15.38%
Premenstrual Syndrome: 1 person, 7.69%
Ischaemic Cerebral Infarction (ischemic stroke resulting from a disturbance in the blood vessels supplying blood to the brain): 1 person, 7.69%
High Blood Cholesterol: 1 person, 7.69%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 7.69%
Complicated Migraine (weakness, loss of vision, or difficulty speaking in addition to the headache): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Depacon and have Drug ineffective?

- Check whether Drug ineffective is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Depacon:

Depacon (268 reports)

Drug ineffective treatments and more:

Drug ineffective (1,349,510 reports)

Browse all side effects of Depacon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drug ineffective:

Drug ineffective (4,081 drugs)

Browse all the conditions that are associated with Drug ineffective:

Drug ineffective (5,194 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on valproate sodium (the active ingredients of Depacon) and Depacon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.